Bio-Rad Labs (BIO) Tops Q2 EPS by 32c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $270.32 --0%
Revenue Growth %: -4.3%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
CRWS, MEI, PODC, More
Revenue Growth %: -4.3%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
CRWS, MEI, PODC, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $3.00, $0.32 better than the analyst estimate of $2.68. Revenue for the quarter came in at $681.1 million versus the consensus estimate of $697.96 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
